National Prion Disease Pathology Surveillance Center to receive up to $20 million in CDC grant funding for continued research into fatal neurodegenerative prion diseases in brain

The National Prion Disease Pathology Surveillance Center (NPDPSC) at Case Western Reserve University will receive up to $20 million in funding as part of a grant renewal from the Centers for Disease Control and Prevention (CDC) to better understand how and why prion diseases––degenerative brain conditions found in both humans and animals—develop and spread.

Testing Wastewater for COVID-19

UNLV researcher Edwin Oh and colleagues have implemented wastewater surveillance programs to screen samples for the presence of COVID-19 and to extract the RNA from the SARS-COV-2 virus to find targets that make vaccines more effective.

The Do’s and Don’ts of Face Masks

Face masks are an important part of staying safe during the COVID-19 pandemic. But not all masks are created equal. And if you don’t wear and handle your mask properly, it won’t protect you or others around you.

So which masks work—and which don’t? And how do you safely wear one? Marisa Glucoft, MPH, CIC, Director of Accreditation and Licensing, Infection Prevention and Emergency Management at Children’s Hospital Los Angeles, shares what you need to know.

Tulane University launches new coronavirus research program to develop a vaccine and advanced diagnostics

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

Mount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine

A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).